From Inc · · 1m 20s
Pill for Erectile Dysfunction Slowed Alzheimer’s Decline by 31 Percent
New pill for erectile dysfunction may slow Alzheimer’s disease progression by 31 percent in some patients.
In brief
New pill for erectile dysfunction may slow Alzheimer’s disease progression by 31 percent in some patients. A pill for erectile dysfunction slowed Alzheimer’s decline by 31 percent in a specific group of patients. Originally reported by Inc.
New Pill for Erectile Dysfunction
A pill developed to treat erectile dysfunction may slow Alzheimer’s disease progression by 31 percent in some patients.
AR1001 Slowed Alzheimer’s Decline
AR1001, a South Korean company’s product, slowed clinical decline by 31 percent compared with a placebo over a year.
Trial Results at CTAD Conference
Researchers presented results at the Clinical Trials on Alzheimer’s Disease conference in Boston on Monday.
31 Percent Result Limited to Group
The 31 percent figure applied only to participants not taking two common dementia drugs.
Trial Details
The Phase 3 trial enrolled 1,535 people with early Alzheimer’s disease across 13 countries.
Drug Administration
Participants took 30 milligrams of AR1001 or a placebo once daily for a year.
Cognitive Decline Measurement
Researchers tracked cognitive decline using the Clinical Dementia Rating, Sum of Boxes system.
Fred Kim’s Statement
Fred Kim, AriBio’s U.S. managing director, called the results an important milestone for Alzheimer’s treatments.
The one thing
A pill for erectile dysfunction slowed Alzheimer’s decline by 31 percent in a specific group of patients.
Read the TL;DR — this story on one card.




